BWXT · Analysis updated Nov 10, 2026, 6:00 PM ET

Why is BWX Technologies, Inc. (BWXT) stock moving?

BWXT reported Q3 2026 adjusted EPS of $1.26, above the $1.19 estimate, but revenue of $953 million missed the $970 million consensus by about 1.8%. Full-year adjusted EPS guidance was narrowed to $4.72-$4.77 against a $4.74 estimate, while the $3.800 billion sales outlook was affirmed, and management reaffirmed long-term targets and raised the low end of 2026 free cash flow guidance. Deutsche Bank trimmed its target to $190 from $196 but kept a Buy rating. The stock fell from a $137.93 close on Oct 29 to $130.47 on Nov 2, then dropped sharply to a $114.96 low on Nov 5 on roughly 3.3 million shares, about three times normal volume, the same days the company launched a $500 million senior notes offering and tender offers for its 2028 and 2029 notes. The news does not state a reason for the drop, so the link to the offering is one of timing only. The stock rebounded to $127.99 on Nov 9 on 1.33 million shares, after the company disclosed a $1.6 billion uranium facility build, the PCG acquisition and an agreement to divest its medical business, and closed at $126.64 on Nov 10. The recovery is strong, but the medical divestiture and PCG deal are sourced only from a weekly recap, and the refinancing and sales miss still weigh on sentiment.

News behind the analysis

About BWX Technologies, Inc.

Industrials · Aerospace & Defense (nuclear components and fuel)

BWX Technologies is a Lynchburg, Virginia–based nuclear manufacturer and engineering company with about 11,000 employees. It is the main supplier of nuclear reactors and fuel for US Navy submarines and aircraft carriers, and it is growing a commercial nuclear power business too.

How it makes money

Most of its revenue, very roughly two-thirds, comes from the Government Operations segment. That segment builds naval nuclear reactor components and fuel under long-term US government contracts, and it also does uranium processing, site management and advanced reactor work such as microreactors and TRISO fuel. The Commercial Operations segment brings in about $1.2B (2026 outlook). It supplies components, fuel and services to nuclear power plants, mainly in Canada but increasingly worldwide. It has grown through acquisitions such as Kinectrics and Precision Components Group. Total 2026 sales are about $3.8B. The company has agreed to sell its medical isotopes business.

What usually moves BWXT

Similar companies

HII, GD, CW, LEU, CCJ

All stock analyses · Stock market today

This analysis is for informational purposes only and is not investment advice. Figures are based on the news and market data provided and may be incomplete or outdated.